rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

PMGC Holdings Inc.

ELAB · Nasdaq

Health CareBiotechnologyNot moving yetGLP-1GLP-1

ELAB stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 83.5% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
11 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders11+5 on the quarter
New · exited6 · 1
Reported value$302K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCadded · filed 14 Aug 202681,501$99K+49,907+158.0%
MORGAN STANLEYadded · filed 13 Aug 202653,000$64K+38,000+253.3%
VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 202634,014$41K+34,014
GEODE CAPITAL MANAGEMENT, LLCnew · filed 12 Aug 202624,077$29K+24,077
CITADEL ADVISORS LLCnew · filed 14 Aug 202620,702$25K+20,702
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 202616,672$20K+16,672
XTX Topco Ltdnew · filed 14 Aug 202614,148$17K+14,148
Tower Research Capital LLC (TRC)added · filed 11 Aug 20262,505$3,031+2,376+1841.9%
UBS Group AGadded · filed 13 Aug 20262,352$2,846+1,050+80.6%
IFP Advisors, Increduced · filed 20 Jul 20261,000$1,210-1,000−50.0%
31 Dec 2023 – 30 Jun 2026
1611Dec 23Sep 24Mar 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

George Kovalyov Company insiderDirector · last 1 Jun 20260 · 0
Graydon Bensler Company insiderChief Executive Officer · last 1 Jun 20260 · 0
Jeffrey Parry Company insiderDirector · last 1 Jun 20260 · 0
Juliana Daley Company insiderDirector · last 1 Jun 20260 · 0
Lichti Braeden Company insiderDirector · last 1 Jun 20260 · 0
Bwl Investments Ltd. Company insider10% owner · last 28 Dec 20230 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202531.4%
Research spendFY 2025 · to 31 Dec 202524.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$5.4M
Free cash flowFY 2025 · to 31 Dec 2025−$6.4M

Analyst forecasts

No analyst forecasts yet.